What is the ROE (Return on Equity) of Resmed this year?
The ROE of Resmed this year is 0.22 undefined.
Resmed ROE 2024
Resmed ROE
0.22
Resmed Dividend yield
0.85 %
Ticker
RMD
ISIN
US7611521078
WKN
895878
In 2024, Resmed's return on equity (ROE) was 0.22, a -6.29% increase from the 0.23 ROE in the previous year.
Resmed Aktienanalyse
What does Resmed do?
ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Resmed's Return on Equity (ROE)
Resmed's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Resmed's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Resmed's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Resmed’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Resmed Stock
How has the Return on Equity (ROE) of Resmed developed compared to the previous year?
The ROE of Resmed has increased by -6.29% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Resmed?
A high ROE indicates that Resmed generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Resmed?
A low ROE can indicate that Resmed is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Resmed affect the company?
A change in ROE (Return on Equity) of Resmed can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Resmed?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Resmed?
Some factors that can influence Resmed's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Resmed pay?
Over the past 12 months, Resmed paid a dividend of 1.84 USD . This corresponds to a dividend yield of about 0.85 %. For the coming 12 months, Resmed is expected to pay a dividend of 2.11 USD.
What is the dividend yield of Resmed?
The current dividend yield of Resmed is 0.85 %.
When does Resmed pay dividends?
Resmed pays a quarterly dividend. This is distributed in the months of September, December, March, June.
How secure is the dividend of Resmed?
Resmed paid dividends every year for the past 0 years.
What is the dividend of Resmed?
For the upcoming 12 months, dividends amounting to 2.11 USD are expected. This corresponds to a dividend yield of 0.97 %.
In which sector is Resmed located?
Resmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Resmed from 6/13/2024 amounting to 0.48 USD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.
When did Resmed pay the last dividend?
The last dividend was paid out on 6/13/2024.
What was the dividend of Resmed in the year 2023?
In the year 2023, Resmed distributed 1.72 USD as dividends.
In which currency does Resmed pay out the dividend?
The dividends of Resmed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Resmed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Resmed
Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
